JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 45 filers reported holding JANUX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,526,956 | +16.6% | 1,639,579 | +37.3% | 0.00% | – |
| Q2 2023 | $14,179,758 | +3.3% | 1,194,588 | +5.3% | 0.00% | – |
| Q1 2023 | $13,729,205 | -5.5% | 1,134,645 | +2.9% | 0.00% | – |
| Q4 2022 | $14,527,234 | -14.2% | 1,103,055 | -11.8% | 0.00% | -100.0% |
| Q3 2022 | $16,929,000 | +14.7% | 1,250,348 | +3.5% | 0.00% | – |
| Q2 2022 | $14,754,000 | -11.4% | 1,208,354 | +4.0% | 0.00% | – |
| Q1 2022 | $16,659,000 | -16.3% | 1,161,721 | +15.2% | 0.00% | -100.0% |
| Q4 2021 | $19,892,000 | +14.7% | 1,008,261 | +25.8% | 0.00% | – |
| Q3 2021 | $17,341,000 | +532.2% | 801,778 | +629.2% | 0.00% | – |
| Q2 2021 | $2,743,000 | – | 109,947 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $105,869,000 | 2.82% |
| 5AM Venture Management, LLC | 446,266 | $5,449,000 | 1.35% |
| Samsara BioCapital, LLC | 360,414 | $4,401,000 | 1.17% |
| BVF INC/IL | 1,470,334 | $17,953,000 | 0.87% |
| Orbimed Advisors | 2,836,386 | $34,632,000 | 0.63% |
| EcoR1 Capital, LLC | 1,421,319 | $17,354,000 | 0.60% |
| Parkwood LLC | 33,750 | $412,000 | 0.07% |
| Woodline Partners LP | 286,383 | $3,497,000 | 0.05% |
| Cerity Partners LLC | 150,933 | $1,843,000 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,127,797 | $25,966,000 | 0.02% |